a phase ii clinical trial on mds was conducted in a cooperative study with orally administrable ara-c analogue , plac , which is resistant to cytidine deaminase and had shown an anti-tumor activity on various experimental tumors by oral route .
C0027659
tumor
C0027651
tumors